New study aims to predict dangerous immunotherapy side effects before they happen

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient (≥18 years old) * Patient presenting an histologically or cytologically confirmed solid tumour malignancy * Patient scheduled to receive his/her first infusion of immunotherapy with anti-PD1, anti-PDL1, anti-CTLA4, anti-LAG3, alone or in combination, as part of standard care, in all validated solid oncology indications. * Patient must have at least one measurable lesion according to RECIST 1.1 criteria * Patient treated at AP-HM in one of the CEPCM-affiliated departments. * Patient able to comply with study procedures and follow-up schedule * Patient who has been informed about the study and signed the consent form * Patient who is a beneficiary or entitled beneficiary of a social security scheme Exclusion Criteria: * Patient previously treated with ICIs * Patient whose treatment plan includes targeted therapy, chemotherapy or any other systemic treatment in combination with ICI * Patient included in a trial with an experimental molecule * Patient has an active autoimmune disease or any other pathology requiring systemic corticosteroid therapy at more than 10 mg prednisone equivalent per day or any other immunosuppressive drug * Patients with a history of organ transplantation, hematopathy or hematopoietic stem cell transplantation * Patient with history or current evidence of any condition, therapy, laboratory abnormality, or other circumstance that might confound the results of the study or interfere with the participant's participation for the full duration of the study, such that it is not in the best interest of the participant to participate, in the opinion of the treating investigator. * Patient in emergency situations, persons deprived of their liberty by judicial or administrative decision, adults subject to legal protection measures, or persons who are unable to give their consent, or pregnant or breastfeeding.